Read More Pharma Industry News Orchard Therapeutics raises $150m in Series C funding to advance gene therapies for rare diseases Orchard Therapeutics, a leader in gene therapy specializing in rare diseases, has successfully secured $150 million through a… bypharmanewsdailyAugust 15, 2018
